On Monday, Seres Therapeutics Inc (NASDAQ: MCRB) was 2.08% jump from the session beforebefore settling in for the closing price of $1.00. A 52-week range for MCRB has been $0.54 – $3.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 386.36% over the past five years. When this article was written, the company’s average yearly earnings per share was at 11.26%. With a float of $120.71 million, this company’s outstanding shares have now reached $135.04 million.
Let’s look at the performance matrix of the company that is accounted for 233 employees. In terms of profitability, gross margin is -1918.98%, operating margin of -43457.49%, and the pretax margin is -43343.58%.
Seres Therapeutics Inc (MCRB) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Seres Therapeutics Inc stocks. The insider ownership of Seres Therapeutics Inc is 20.78%, while institutional ownership is 30.17%. The most recent insider transaction that took place on Aug 16 ’24, was worth 733. In this transaction Chief Legal Officer and EVP of this company sold 873 shares at a rate of $0.84, taking the stock ownership to the 124,173 shares. Before that another transaction happened on Aug 16 ’24, when Company’s See Remarks sold 973 for $0.84, making the entire transaction worth $817. This insider now owns 21,013 shares in total.
Seres Therapeutics Inc (MCRB) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.37 earnings per share (EPS) during the time that was better than consensus figure (set at -0.5) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.26% per share during the next fiscal year.
Seres Therapeutics Inc (NASDAQ: MCRB) Trading Performance Indicators
You can see what Seres Therapeutics Inc (MCRB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 420.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Seres Therapeutics Inc (MCRB)
Seres Therapeutics Inc (NASDAQ: MCRB) saw its 5-day average volume 3.79 million, a negative change from its year-to-date volume of 4.48 million. As of the previous 9 days, the stock’s Stochastic %D was 40.56%. Additionally, its Average True Range was 0.13.
During the past 100 days, Seres Therapeutics Inc’s (MCRB) raw stochastic average was set at 47.24%, which indicates a significant increase from 45.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.32% in the past 14 days, which was lower than the 152.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0353, while its 200-day Moving Average is $0.9903. Nevertheless, the first resistance level for the watch stands at $1.0662 in the near term. At $1.1123, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.1547. If the price goes on to break the first support level at $0.9777, it is likely to go to the next support level at $0.9353. Assuming the price breaks the second support level, the third support level stands at $0.8892.
Seres Therapeutics Inc (NASDAQ: MCRB) Key Stats
There are 151,448K outstanding shares of the company, which has a market capitalization of 155.43 million. As of now, sales total 126,330 K while income totals -113,720 K. Its latest quarter income was 0 K while its last quarter net income were -40,130 K.
